Number of Applicants
:000+
Let AI Supercharge Your Job Hunt!
JobCopilot scans 500,000+ company career sites daily to find jobs for you
ATUM exists to support courageous founders who turn differentiating tech into world-changing companies that solve critical challenges in Energy, Medtech and Advanced Manufacturing. We bring capital, operational muscle and partners from academia, industry, VC, and government who co-invest in every build.
ATUM builds ventures from scratch by helping researchers, corporates and founders turn breakthrough research into venture-scale companies, backing them with capital, corporate networks, and the operational guidance to navigate everything from technical validation and grants to go-to-market and growth. We built and invested in 15 deep-tech ventures so far and have a portfolio of fast-growing ventures that are scaling globally.
Our Deep Tech Venture Building Programme leads the end‑to‑end creation of new startups from breakthrough technologies. We identify research‑backed innovations, validate them with our scientific council, assemble complementary founder teams and support these teams towards investment readiness and launch.
Aproxy is building a next-generation diagnostics platform to solve one of healthcare’s biggest bottlenecks: most clinical decisions depend on proteins, yet protein tests are slow, complex, and insensitive. Around 70% of medical decisions rely on lab tests, but key disease biomarkers exist at extremely low concentrations and cannot be amplified like DNA. As a result, samples are sent to central labs, results take days, and diagnosis and treatment are delayed, sometimes costing tens or hundreds of thousands of dollars per patient in avoidable medical and productivity losses. This problem is even more acute in veterinary medicine, where small sample volumes, fast disease progression, and weak follow-up make delays especially costly.
Aproxy’s patented technology converts protein signals into DNA signals, unlocking 100–1,000× higher sensitivity than standard immunoassays in a one-pot, 20–30 minute workflow, with no wash steps and no new hardware. It delivers reference-lab–level sensitivity at point-of-care speed, enabling earlier detection, same-visit decisions, and entirely new tests that were previously impractical or impossible. The platform is chemistry-first, instrument-agnostic, and protected by multiple patent families covering the core protein-to-DNA mechanism and noise-suppression designs.
We are looking for a future ATUM Commercial Founder to take this next wave of high-impact technologies out into the world. As a Commercial Founder, you'll lead the business and GTM strategy and execution from day one. You’ll pair with the Technical Founder to build a high-impact business, and set the foundations for scale & impact.
This is not a “job.” It’s a founding journey. You’ll share in the risk, the upside, and the impact.
You will be responsible for shaping the go-to-market and commercial strategy of a new deep-tech startup. You will work alongside the founder and inventor, who leads the scientific development, to identify a viable market application, build customer traction and secure funding to take your venture forward for scale.
ATUM is an equal opportunity employer and partner, whether you are exploring joining our team, our Venture Build Programme, or one of our Portfolio Companies. We welcome applicants of all backgrounds and identities, and our selection decisions are guided by our core values. If our mission resonates with you, we encourage you to apply.
Auto-Apply to Commercial Founder Jobs with your AI JobCopilot
Copyright © 2026 Grabjobs Pte.Ltd. All Rights Reserved.